17-alpha-hydroxyprogesterone has been researched along with verapamil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, K; Stiefl, N | 1 |
| Alameh, G; Barret, R; Beltran, S; Cuilleron, CY; de Ravel, MR; Dumontet, C; El Jawad, L; Emptoz-Bonneton, A; Grenot, C; Le Borgne, M; Lomberget, T; Mahiout, Z; Mappus, E; Matera, EL; Melikian, M; Pugeat, M; Rocheblave, L; Walchshofer, N | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and verapamil
| Article | Year |
|---|---|
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
Topics: Acetates; Alcohols; Algorithms; Cholinergic Agents; Hydrocarbons, Acyclic; Hydrocarbons, Aromatic; Ketones; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Receptor, Muscarinic M2; Receptors, Muscarinic; Steroids; Transcortin | 2003 |
Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Models, Molecular; Molecular Conformation; Progesterone; Tumor Cells, Cultured | 2015 |